123 Results

People

  1. Motzer
    Motzer
  2. Saltz
    Saltz
  3. Dickler
    Dickler
  4. Jaimes
    Jaimes
  5. Glezerman
    Glezerman
  6. Miller
    Miller
  7. Aghajanian
    Aghajanian
  8. Flombaum
    Flombaum
  9. Hudis
    Hudis
  10. Lichtman
    Lichtman

Groups

  1. Department of Medicine (82)
  2. Solid Tumor Oncology Division (63)
  3. Genitourinary Oncology Service (23)
  4. Division of Subspecialty Medicine (17)
  5. Renal (16)
  6. Gastrointestinal Oncology Service (15)
  7. Gynecologic Medicine Service (13)
  8. Center for Hematologic Malignancies (12)
  9. Hematologic Malignancies, Division of (12)
  10. Survivorship Research (12)
  1. "proteinuria"
Formats
  1. Journal Article (116)
  2. Review (3)
  3. Book Section (2)
  4. Research Letter (2)
Groups
  1. Department of Medicine (82)
  2. Solid Tumor Oncology Division (63)
  3. Genitourinary Oncology Service (23)
  4. Division of Subspecialty Medicine (17)
  5. Renal (16)
  6. Gastrointestinal Oncology Service (15)

More Groups

People
  1. Robert Motzer (19)
  2. Leonard Saltz (8)
  3. Ilya Glezerman (7)
  4. Edgar Jaimes (6)
  5. Maura Dickler (6)
  6. Vincent Miller (5)

More People

Years
  1. 2025 (3)
  2. 2024 (9)
  3. 2023 (5)
  4. 2022 (2)
  5. 2021 (3)
  6. 2020 (8)

More Years

Publications
  1. Journal of Clinical Oncology (11)
  2. Clinical Cancer Research (5)
  3. Lancet Oncology (5)
  4. The Oncologist (4)
  5. Annals of Oncology (3)
  6. Cancer Science (3)

More Publications

Publishers
  1. Elsevier Inc. (25)
  2. Oxford University Press (12)
  3. American Society of Clinical Oncology (11)
  4. Elsevier Science, Inc. (8)
  5. Nature Publishing Group (8)
  6. Wiley Blackwell (7)

More Publishers

Results (123)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Urine-free response criteria predict progression-free survival in multiple myeloma: A post hoc analysis of BMT CTN 0702
    Research Letter

    Banerjee, R.; Fritz, A. R.; Akhtar, O. S.; Freeman, C. L.; Cowan, A. J.; Shah, N.; Landau, H. J.; Kumar, S. K.; Vogl, D. T.; Efebera, Y. A.; more...
    Leukemia (2025)

    Fulltext@MSK | Save
  • Endosomal chloride/proton exchangers need inhibitory TMEM9 β-subunits for regulation and prevention of disease-causing overactivity
    Journal Article

    Planells-Cases, R.; Vorobeva, V.; Kar, S.; Schmitt, F. W.; Schulte, U.; Schrecker, M.; Hite, R. K.; Fakler, B.; Jentsch, T. J.
    Nature Communications (2025)

    Fulltext@MSK | Save
  • Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): A multiregional, randomised, double-blind, placebo-controlled, phase 3 study
    Journal Article

    Sangro, B.; Kudo, M.; Erinjeri, J. P.; Qin, S.; Ren, Z.; Chan, S. L.; Arai, Y.; Heo, J.; Mai, A.; Escobar, J.; more...
    Lancet (2025)

    Fulltext@MSK | Save
  • Lenvatinib plus ifosfamide and etoposide in children and young adults with relapsed osteosarcoma: A phase 2 randomized clinical trial
    Journal Article

    Gaspar, N.; Hung, G. Y.; Strauss, S. J.; Campbell-Hewson, Q.; Dela Cruz, F. S.; Glade Bender, J. L.; Koh, K. N.; Whittle, S. B.; Chan, G. C. F.; Gerber, N. U.; more...
    JAMA Oncology (2024)

    Fulltext@MSK | Save
  • Graded organ response and progression criteria for kidney immunoglobulin light chain amyloidosis
    Journal Article

    Muchtar, E.; Wisniowski, B.; Geyer, S.; Palladini, G.; Milani, P.; Merlini, G.; Schönland, S.; Veelken, K.; Hegenbart, U.; Leung, N.; more...
    JAMA Oncology (2024)

    Fulltext@MSK | Save
  • Tivozanib plus nivolumab versus tivozanib monotherapy in patients with renal cell carcinoma following an immune checkpoint inhibitor: Results of the phase 3 TiNivo-2 study
    Journal Article

    Choueiri, T. K.; Albiges, L.; Barthélémy, P.; Iacovelli, R.; Emambux, S.; Molina-Cerrillo, J.; Garmezy, B.; Barata, P.; Basu, A.; Bourlon, M. T.; more...
    Lancet (2024)

    Fulltext@MSK | Save
  • Genetically conditioned interaction among microRNA-155, alpha-klotho, and intra-renal RAS in male rats: Link to CKD progression
    Journal Article

    Harrison-Bernard, L. M.; Raij, L.; Tian, R. X.; Jaimes, E. A.
    Physiological Reports (2024)

    Fulltext@MSK | Save
  • Immunotactoid glomerulopathy
    Review

    Abramson, M.; Shaikh, A.
    Advances in Kidney Disease and Health (2024)

    Fulltext@MSK | Save
  • Successful use of narsoplimab to treat allogeneic transplant-associated thrombotic microangiopathy while maintaining sirolimus
    Research Letter

    Alhomoud, M.; Scordo, M.; Perales, M. A.
    Bone Marrow Transplantation (2024)

    Fulltext@MSK | Save
  • Addition of temsirolimus to chemotherapy in children, adolescents, and young adults with intermediate-risk rhabdomyosarcoma (ARST1431): A randomised, open-label, phase 3 trial from the Children's Oncology Group
    Journal Article

    Gupta, A. A.; Xue, W.; Harrison, D. J.; Hawkins, D. S.; Dasgupta, R.; Wolden, S.; Shulkin, B.; Qumseya, A.; Routh, J. C.; MacDonald, T.; more...
    Lancet Oncology (2024)

    Fulltext@MSK | Save